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Introduction:  
Crohn’s disease is classified as chronic inflammatory bowel disease. The incidence in Europe ranges 
from 1 to almost 11.4 per 100,000 population per year. Ultrasound examination plays an important role 
in imaging diagnostics of inflammatory bowel lesions. It allows for assessing response to therapy as 
well as recognizing possible penetrating complications of the disease, i.e. fistula or abscess. 
Materials and Methods:  
36 children were included in the study: 16 boys and 20 girls with an active phase of Crohn’s disease. 
Each patient underwent intestinal ultrasound examination with a high frequency 7-12 Mhz linear 
probe.  
Results:  
In all patients US examination depicted a thickened, hypoechoic ileal wall showing patterns of 
vascularization. In 8 patients Bauhin’ valve edema was visible. In 16 children, inflammatory infiltration 
of the peri intestinal fat around the affected segment of the intestine was found.  In addition, all 
patients presented mesenteric lymphadenopathy with short-axis diameter of 10-15 mm. 8 patients had 
penetrating complications of Crohn's disease: 4 small intestine fistulas and 4 abscesses. 
Conclusion:  
Given its safety profile and diagnostic efficacy, US examination should be considered as the first-line 
imaging modality for assessing inflammatory bowel disease in children. The US proved to be a reliable 
and easily accessible tool in the diagnosis of enteric inflammatory lesions, evaluating CD activity and 
assessing potential penetrating complications of the disease. 
Keywords: Ultrasound, Inflammatory Bowel Disease, pediatric patients 
 
